Supplementary Health Insurance in Turkey von Deger, C.C, Tuna, E, Ozdemir, Z, Ozel, M.O, Parali, E, Sumer, F, Yilmaz, Z.S

Volltext

How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products? von Deger, C.C, Tuna, E, Ozdemir, Z, Ozel, M.O, Parali, E, Sumer, F, Yilmaz, Z.S

Volltext

External Reference Pricing (Erp) In Turkey And Its Effects On Countries That Refer To Turkey von Deger, C, Ozdemir, A.Z, Sumer, F, Parali, E, Yilmaz, Z.S, Tunalioglu, A, Ustunel, B, Ozel, M.O

Volltext

Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey? von Tuna, E, Deger, C, Marmarali, B, Ozel, M.O, Parali, E, Sumer, F, Yilmaz, Z.S

Volltext

The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey von Parali, E, Deger, C, Ozdemir, O, Afsar, N, Aykut Aka, S, Degertekin, M, Ergene, O, Ongen, Z, Ozdemir, M, Sumer, F, Yilmaz, Z.S, Ozel, M.O

Volltext

The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of cost... von Deger, C, Ozdemir, O, Bozkurt, K, Demir, M, Ince, B, Kultursay, H, Ongen, G, Ongen, Z, Marmarali, B, Ozel, M.O, Parali, E, Sumer, F, Tuna, E, Yilmaz, Z.S

Volltext

The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey von Marmarali, B, Ozdemir, O, Bozkurt, K, Demir, M, Ince, B, Kultursay, H, Ongen, G, Ongen, Z, Deger, C, Ozel, M.O, Parali, E, Sumer, F, Tuna, E, Yilmaz, Z.S

Volltext

The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs von Deger, C, Ozdemir, O, Bozkurt, K, Demir, M, Ince, B, Kultursay, H, Ongen, G, Ongen, Z, Marmarali, B, Ozel, M.O, Parali, E, Sumer, F, Tuna, E, Yilmaz, Z.S

Volltext

The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey von Parali, E, Ozdemir, O, Bozkurt, K, Demir, M, Ince, B, Kultursay, H, Ongen, G, Ongen, Z, Deger, C, Marmarali, B, Ozel, M.O, Sumer, F, Tuna, E, Yilmaz, Z.S

Volltext

PHP120 - External Reference Pricing (Erp) In Turkey And Its Effects On Countries That Refer To Turkey von Deger, C., Ozdemir, A.Z., Sumer, F., Parali, E., Yilmaz, Z.S., Tunalioglu, A., Ustunel, B., Ozel, M.O.

Volltext

PHP1 - How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products? von Deger, C.C., Tuna, E., Ozdemir, Z., Ozel, M.O., Parali, E., Sumer, F., Yilmaz, Z.S.

Volltext

PHP3 - Supplementary Health Insurance in Turkey von Deger, C.C., Tuna, E., Ozdemir, Z., Ozel, M.O., Parali, E., Sumer, F., Yilmaz, Z.S.

Volltext

PHP75 - Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey? von Tuna, E., Deger, C., Marmarali, B., Ozel, M.O., Parali, E., Sumer, F., Yilmaz, Z.S.

Volltext

PCV78 - The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey von Parali, E, Deger, C., Ozdemir, O., Afsar, N., Aykut Aka, S., Degertekin, M., Ergene, O., Ongen, Z., Ozdemir, M., Sumer, F., Yilmaz, Z.S., Ozel, M.O.

Volltext

PCV55 - The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation... von Deger, C., Ozdemir, O., Bozkurt, K., Demir, M., Ince, B., Kultursay, H., Ongen, G., Ongen, Z., Marmarali, B., Ozel, M.O., Parali, E., Sumer, F., Tuna, E., Yilmaz, Z.S.

Volltext

PCV58 - The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs von Deger, C., Ozdemir, O., Bozkurt, K., Demir, M., Ince, B., Kultursay, H., Ongen, G., Ongen, Z., Marmarali, B., Ozel, M.O., Parali, E., Sumer, F., Tuna, E., Yilmaz, Z.S.

Volltext

PCV90 - The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey von Parali, E., Ozdemir, O., Bozkurt, K., Demir, M., Ince, B., Kultursay, H., Ongen, G., Ongen, Z., Deger, C., Marmarali, B., Ozel, M.O., Sumer, F., Tuna, E., Yilmaz, Z.S.

Volltext

PCV78 - The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey von Marmarali, B., Ozdemir, O., Bozkurt, K., Demir, M., Ince, B., Kultursay, H., Ongen, G., Ongen, Z., Deger, C., Ozel, M.O., Parali, E., Sumer, F., Tuna, E., Yilmaz, Z.S.

Volltext

PP15.11 – 3031: Brain magnetic resonance imaging findings in children with recurrent headache von Gurkas, E, Karalok, Z.S, Taskin, B.D, Aydogmus, U, Yilmaz, C, Arhan, E, Kabacam, G.B

Volltext

P109 – 2442: Infantile neuroaxonal dystrophy: A new mutation von Karalok, Z.S, Taskin, B.D, Aydogmus, U, Ceylaner, S, Karaer, K, Yilmaz, C

Volltext